| Wang, Jianan |
NCT05260411: A Study to Evaluate the Efficacy and Safety of AK102 Q6W in Patients With Hyperlipidemia |
|
|
| Recruiting | 3 | 240 | RoW | AK102, Placebo | Akeso | Hyperlipidemia | 06/22 | 12/22 | | |
| Completed | 3 | 226 | Europe, Canada, US, RoW | Bentracimab (PB2452) Infusion | SFJ Pharmaceuticals, Inc. | Hemorrhage, Urgent Surgery, Invasive Procedure | 09/24 | 09/24 | | |
NCT06109831: Evaluate the Efficacy and Safety of SHR-1918 in Patients With Hyperlipidemic |
|
|
| Active, not recruiting | 2 | 335 | RoW | SHR-1918, SHR-1918 placebo | Beijing Suncadia Pharmaceuticals Co., Ltd | Hyperlipidemic | 10/24 | 09/25 | | |
NCT02698839: A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES) |
|
|
| Active, not recruiting | N/A | 539 | RoW | BuMA Supreme, BuMA™ | Sino Medical Sciences Technology Inc. | Coronary Artery Disease | 03/18 | 12/25 | | |
OPC, NCT02698852: A Study to Evaluate the Efficacy and Safety of BuMA Supreme Drug Eluting Stent(DES) |
|
|
| Active, not recruiting | N/A | 1000 | RoW | BuMA Supreme | Sino Medical Sciences Technology Inc. | Coronary Artery Disease | 05/19 | 12/25 | | |
NCT05888246: Measuring the Range of Cardiac Magnetic Parameters in Healthy Subjects by Magnetocardiogram |
|
|
| Completed | N/A | 412 | RoW | Magnetocardiogram | Hangzhou Nuochi Life Science Co., Ltd. | Healthy People | 05/22 | 05/22 | | |
NCT04921605: Feasibility Study of Dragonfly System for Severe Tricuspid Regurgitation |
|
|
| Enrolling by invitation | N/A | 10 | RoW | DragonFly transcatheter mitral valve clamping system | Hangzhou Valgen Medtech Co., Ltd | Tricuspid Regurgitation | 09/22 | 06/23 | | |
| Enrolling by invitation | N/A | 20 | RoW | Dragonfly mitral valve repair system | Hangzhou Valgen Medtech Co., Ltd | Mitral Regurgitation | 12/22 | 12/23 | | |
| Active, not recruiting | N/A | 52 | RoW | Medtronic CoreValve™ Evolut™ PRO System | Medtronic Cardiovascular | Severe, Symptomatic Aortic Stenosis | 03/23 | 05/28 | | |
| Recruiting | N/A | 120 | RoW | Transcatheter aortic valve replacement | Genesis Medtech Corporation | Diseases of Aortic Valve, Aortic Regurgitation Disease | 05/23 | 05/24 | | |
NCT05607667: Clinical Trial in China for Aortic Valve Stenosis |
|
|
| Recruiting | N/A | 53 | RoW | Transcatheter aortic valve replacement | Genesis Medtech Corporation | Diseases of Aortic Valve, Aortic Stenosis Disease | 05/23 | 05/23 | | |
NCT04734756: Safety and Effectiveness Study of Dragonfly System for Degenerative Mitral Regurgitation |
|
|
| Enrolling by invitation | N/A | 120 | RoW | Dragonfly Transcatheter Mitral Valve Repair System | Hangzhou Valgen Medtech Co., Ltd | Degenerative Mitral Valve Disease | 05/23 | 05/27 | | |
NCT04733404: Safety and Effectiveness Study of Dragonfly System for Functional Mitral Regurgitation |
|
|
| Recruiting | N/A | 120 | RoW | Dragonfly Transcatheter Mitral Valve Repair System | Hangzhou Valgen Medtech Co., Ltd | Mitral Regurgitation Functional | 09/23 | 09/27 | | |
| Enrolling by invitation | N/A | 239 | RoW | Coronary atherectomy system of Shanghai MicroPort Rhythm, Stenting will be applied in both arms, Rotablator Rotational Atherectomy System | Shanghai MicroPort Rhythm MedTech Co., Ltd. | Calcification of Coronary Artery | 12/23 | 12/24 | | |
NCT06101888: Safety and Effectiveness of TaurusTrio™ Heart Valve System in Patients With Severe Aortic Regurgitation (AR) |
|
|
| Recruiting | N/A | 116 | RoW | TaurusTrio™ Heart Valve System | Peijia Medical Technology (Suzhou) Co., Ltd. | Aortic Regurgitation | 07/24 | 07/29 | | |
VITAL, NCT05977257: VitaFlow® Transcatheter Aortic Valve Replacement System Pre-market Trial Long Term Follow Up （） |
|
|
| Not yet recruiting | N/A | 89 | RoW | VitaFlow® Transcatheter Aortic Valve Replacement System | Shanghai MicroPort CardioFlow Medtech Co., Ltd. | Aortic Valve Disease, Aortic Valve Stenosis | 10/25 | 10/28 | | |
